XT
ICPT

XTX Topco’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

XTX Topco’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-11,558
Closed -$128K – 2145
2023
Q2 		$128K Buy
+11,558
New +$161K 0.02% 1127
2023
Q1 		– Sell
-48,807
Closed -$604K – 1767
2022
Q4 		$604K Buy
+48,807
New +$691K 0.13% 220
2022
Q3 		– Sell
-10,784
Closed -$149K – 1466
2022
Q2 		$149K Buy
+10,784
New +$173K 0.06% 544

Other funds holding ICPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

XTX Topco's ICPT Position: Q3 2023 in Review

XTX Topco sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2023, closing a stake of 11,558 shares — an estimated $128K sold.

XTX Topco first reported a position in ICPT in Q2 2022 and held it in 3 quarters. The position peaked at $604K in Q4 2022. 146 funds tracked by Wall St. Rank hold ICPT as of Q3 2023.

  • XTX Topco reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • XTX Topco sold 11,558 Intercept Pharmaceuticals, Inc. shares in Q3 2023, an estimated $128K.
  • XTX Topco first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2022 and held it in 3 quarters.
  • XTX Topco's Intercept Pharmaceuticals, Inc. position peaked at $604K in Q4 2022.
  • 146 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2023.

Based on XTX Topco's 13F filing for Q3 2023, filed 13 Nov 2023.